March 2, 2021
Dr. Jennifer Hanrahan, an infectious disease specialist and associate professor in the UToledo College of Medicine and Life Sciences, discusses the effectiveness of the steroid dexamethasone as a treatment for COVID-19.
March 1, 2021
Shalini Kota, a second-year medical student at UToledo, discussed how she and her dad invented the Aerosolve Helmet, a personal negative-pressure room of sorts, which COVID-19 patients can wear to reduce the spread of the infectious disease.
February 19, 2021
A physician-researcher at UToledo's College of Medicine and Life Sciences is evaluating whether a common antidepressant might prevent a dangerous complication of COVID-19.
February 15, 2021
Dr. Puneet Sindhwani, a board-certified urologist at UTMC and chair and Kenneth Kropp Endowed Professor of Urology at The University of Toledo College of Medicine and Life Sciences, discusses an innovative new outpatient treatment for prostate cancer that uses ultrasound waves to precisely target and destroy cancerous areas while leaving nearby healthy tissue untouched. Read: ...
February 11, 2021
Nicole Porter, Dr. Yanfa Yan and Rebecca Zietlow were named Distinguished University Professors in recognition of their exemplary achievements in teaching, research, scholarship and professional service.
February 9, 2021
Understanding physiological abnormalities present in PTSD patients may create new methods for treating the mental health condition that affects an estimated 8 million Americans annually.
February 5, 2021
Located in the area previously known as the Mulford Café, the space provides comfortable seating, study tables, computer terminals, a microwave and beverage vending.
February 4, 2021
Fourth-year medical student Luke Zona received the 2020 Excellence in Public Health Award, given to U.S. medical students who advance public health and protect and promote national health and safety.
February 3, 2021
Dr. S. Amjad Hussain was recognized for his "eminent ... contributions to science."
February 2, 2021
UToledo Experts Address COVID-19: Part 3 will take place from 5 to 6 p.m. on Feb. 4 via Webex.
